Press release
Emerging Sub-Segments Transforming the Metabolic Testing Market Landscape
Metabolic Testing Market
Projected Growth and Market Size Forecast for Metabolic Testing
The metabolic testing market is predicted to expand substantially over the coming years, reaching a valuation of $0.91 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 7.3%. The market's upward trajectory is driven by increased adoption of personalized wellness programs, enhanced sports performance analytics, growing preference for remote health monitoring, advancement of wearable metabolic sensors, and greater integration of AI-powered diagnostic tools. Key trends expected to shape the market during the forecast period include personalized metabolic health initiatives, AI-based metabolic rate evaluation, cloud-supported data monitoring, automation in metabolic testing devices, and real-time IoT-enabled body analytics.
Download a free report of the metabolic testing market report:
https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Companies Dominating the Metabolic Testing Industry
Several prominent companies are pivotal players in the metabolic testing market, including Becton dic*kinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., and Vyaire Medical Inc. Other notable firms include Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company (GE Healthcare), Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, and Seca GmbH Co KG.
Recent Strategic Acquisition Enhancing Market Capabilities
In September 2024, Finnish health tech company Oura acquired Veri, a developer of blood sugar monitoring technologies centered on metabolic testing. This acquisition aims to strengthen Oura's health tracking ecosystem by incorporating metabolic insights such as meal timing and glucose monitoring into its app. The integration provides users with a more comprehensive understanding of their metabolic health alongside other wellness metrics.
View the full metabolic testing market report:
https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Innovations and Trends Creating New Openings in Metabolic Testing
Advancements in sensor technology and electrophysiology are creating significant opportunities in the metabolic testing space, particularly in improving cardiac diagnostics and treatments. Companies are focusing on enhancing the accuracy of cardiac mapping, refining ablation procedures, and enabling real-time monitoring of heart electrical signals. This progress helps reduce complications, improve outcomes, and offers more precise treatments for arrhythmias and related heart disorders.
A prime example is Abbott, a US-based healthcare firm that introduced the TactiFlex ablation catheter in February 2023. This device, noted as the world's first ablation catheter with a flexible tip and contact force sensing, is designed to treat atrial fibrillation (AFib). Its laser-cut flexible tip adapts to heart movements, providing superior positioning and stability compared to previous models. The contact force sensor further ensures consistent therapy, shorter operation durations, and enhanced safety.
Key Market Segments Within the Metabolic Testing Industry
The metabolic testing market is divided into several primary segments:
1) Equipment Type, including Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, Electrocardiogram (ECG) Systems, Metabolic Carts, and other related devices.
2) Technology, featuring VO? Max Analysis, Resting Metabolic Rate (RMR) Analysis, and Body Composition Analysis.
3) Applications such as Critical Care, Lifestyle Disease Management, and other uses.
4) End Users comprising Hospitals and Clinics, Sports Training Centers, and other customer groups.
Further subcategories provide detailed classifications:
- Body Composition Analyzers split into Dual-Energy X-ray Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), and Air Displacement Plethysmography (ADP).
- CPET Systems broken down into treadmill or cycle ergometer models, oxygen consumption measurement systems, and gas exchange measurement systems.
- ECG Systems including resting ECG, stress ECG, and Holter monitors.
- Metabolic Carts categorized as indirect calorimetry and open-circuit spirometry models.
- Other equipment types such as continuous glucose monitoring systems, lactate testing devices, and blood pressure monitors.
These segments collectively offer a comprehensive view of the tools and technologies that support metabolic health evaluation across various settings and applications.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Sub-Segments Transforming the Metabolic Testing Market Landscape here
News-ID: 4481239 • Views: …
More Releases from The Business Research Company
Key Players and Competitive Dynamics in the Liver Health Supplements Market
The liver health supplements sector is gaining significant attention as consumers increasingly prioritize holistic wellness and preventive care. With evolving consumer preferences and technological advancements, this market is set to experience robust growth in the coming years. Let's explore the current market size, key drivers, major players, emerging trends, and important segment details shaping this industry.
Forecast of Market Size and Growth Trends in Liver Health Supplements
The liver health…
Market Segmentation, Dynamics, and Competitive Landscape in the Liraglutide Mark …
The liraglutide market is set for significant expansion in the coming years, driven by rising health concerns and evolving treatment preferences worldwide. As demand for effective metabolic disorder therapies grows, this market is poised to deliver substantial growth and innovation through 2030. Let's explore the market size projections, key players, emerging trends, and segmentation details that define the future of liraglutide.
Projected Growth and Size Outlook for the Liraglutide Market Through…
Emerging Sub-Segments Transforming the Levofloxacin Market Landscape
Understanding the future trajectory of the levofloxacin market reveals promising growth driven by evolving healthcare needs and technological advancements. This overview delves into the projected market size, key players, emerging trends, and the segmental breakdown shaping this critical antibiotic sector.
Levofloxacin Market Size Forecast and Expansion to 2030
The levofloxacin market is anticipated to expand significantly through 2030, reaching a valuation of $2.42 billion. This growth corresponds to a compound…
Leading Companies Advancing Innovation and Growth in the Leukemia Therapeutics M …
The leukemia therapeutics market is on the brink of substantial expansion as advancements in treatment strategies and technologies continue to evolve. As researchers and companies focus on more precise and effective therapies, the market is expected to grow significantly by 2030. Here, we explore the anticipated market size, key players, driving forces, and the emerging trends shaping this vital healthcare segment.
Leukemia Therapeutics Market Size and Growth Projections
The leukemia…
More Releases for Metabolic
Metabolic Testing Equipment Market Size to Surge to USD 4.38 Billion by 2035 Dri …
According to Precedence Research, the global metabolic testing equipment size is projected to expand from USD 1.90 billion in 2025 to approximately USD 4.38 billion by 2035, growing at a CAGR of 8.70% from 2026 to 2035. The rising global prevalence of metabolic disorders, including obesity and diabetes, coupled with advancements in diagnostic technologies, is driving the demand for more sophisticated metabolic testing tools. These devices, including metabolic analyzers and…
Evolving Market Trends In The Metabolic Biomarker Testing Industry: Advancements …
The Metabolic Biomarker Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metabolic Biomarker Testing Market Size During the Forecast Period?
The market size for metabolic biomarker testing has seen considerable growth in the past few years. The market is predicted to…
Metabolic Testing Market - Unleash Your Body's Potential: Metabolic Testing for …
Newark, New Castle, USA - new report, titled Metabolic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Metabolic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Metabolic Testing market. The report offers an overview of the market, which…
Comprehensive Metabolic Panel Testing Market Size
The findings reviewed by GME stated that the Global Comprehensive Metabolic Panel Testing Market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Factors like the rising prevalence of chronic diseases, increasing prevalence of Covid-19 and increasing patients, technological advancements, increasing disposable income, growing geriatric population, emphasis on early diagnosis and treatment are expected to support the growth of…
Therapeutic Proteins for Metabolic Disorders Treatment Market is Driven by Incre …
Therapeutic Proteins for Metabolic Disorders Treatment Market: Introduction
Therapeutic proteins are proteins which are engineered in a laboratory for pharmaceutical use. Therapeutic proteins are used as a personalized treatment approach which supports a precisely targeted therapeutic process by making up for the deficiency of an essential protein.
Therapeutic proteins are deliberately adjusted to increase their clinical potential which is followed by enhancements derived from protein or glycol engineering, Fc fusion, or conjugation…
Inherited Metabolic Disorders Market Comprehensive Survey 2025
Global Inherited Metabolic Disorders Market: Overview
Globally, IMD affects nearly one in every 2,500 to 5,000 individuals with nearly 300 to 600 new cases found in the U.K., according to Public Health Genetics U.K. The specificity and high risk affinity of IMD varies from disorder to disorder, with some disorders like familial cylomicronemia being closely associated with Caucasians and others like porphyria being recoded largely among African Americans. These metabolic…
